Title : Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH).

Pub. Date : 2018

PMID : 30071039






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH). Docetaxel erb-b2 receptor tyrosine kinase 3 Homo sapiens